Gestational birth age is strongly correlated with central macular thickness


Prematurely born children have a thicker central macular than children born at term

A recent study featured in the British Journal of Ophthalmology has demonstrated that prematurely born children have a thicker central macular than children born at term.

Professor Gerd Holmström et al., Department of Ophthalmology, University Hospital, Sweden, studied 65 prematurely born children between the ages of 5–16 years and 55 children born at term with Stratus optical coherence tomography (OCT). The foveal minimum, total macular volume and retinal macular thickness in nine macular areas were evaluated.

There was no correlation between macular thickness and refraction or visual acuity. It was found that children with previous retinopathy of prematurity (ROP) had a thicker macular than those who didn't. Children born without ROP still had a thicker macular than the control group. The results revealed that prematurity highly influences central macular thickness and is the most significant risk factor for abnormal foeval development.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.